Medicines you stopped taking years ago may still be shaping the bacteria in your gut. A large study from the University of Tartu Institute of Genomics found that many commonly prescribed drugs leave detectable changes in the gut microbiome long after people stop using them, according to ScienceDaily, which drew on material from the Estonian Research Council.
The researchers stress that the changes are not shown to be harmful. The main message is for scientists: past drug use can explain a good deal of the difference in gut bacteria from one person to the next.
The team examined stool samples and prescription histories from more than 2,500 participants in the Estonian Microbiome cohort, part of the Estonian Biobank. Most of the medications they studied were associated with differences in gut bacteria. A substantial number left microbial "fingerprints" years after patients had stopped taking them.
The gut microbiome is the large community of bacteria and other microorganisms in the digestive tract. These microbes play roles in digestion, immune function and overall health.
The findings went well beyond antibiotics, which are already known to disrupt gut bacteria. Antidepressants, beta-blockers, proton pump inhibitors and benzodiazepines were all linked to differences in the microbiome. Beta-blockers are commonly prescribed for high blood pressure and certain heart conditions, and proton pump inhibitors reduce stomach acid and are often used for acid reflux. Benzodiazepines are often prescribed for anxiety.
Benzodiazepines stood out. The researchers found they were associated with microbiome changes comparable to those seen with broad-spectrum antibiotics, which target a wide range of bacteria. Drugs in the same class did not always behave alike, either. Diazepam and alprazolam are both benzodiazepines used for similar conditions, yet they appeared to differ in how strongly they disrupted gut bacteria.
A study of this kind can show links but not always cause. To test whether the drugs themselves were responsible, the team collected additional stool samples from a smaller group of participants and looked at how the microbiome shifted when people started or stopped certain medications.
They saw predictable shifts, which gave added evidence that the drugs were contributing, not just reflecting differences already present in patients. The follow-up group was relatively small, but the researchers were able to verify lasting effects for several drug categories: proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs, a widely prescribed type of antidepressant), and certain antibiotics, including combinations of penicillins and macrolides.
For patients, the study does not show that any of these medicines cause health problems through the gut, and it offers no reason to change a prescription. The authors say the findings do not establish that the microbial changes are necessarily harmful or that they lead to specific conditions.
The practical weight falls on research and care that relies on microbiome data. Many studies consider only what a person takes now. Lead author Dr. Oliver Aasmets said past drug use can be just as important, calling it a surprisingly strong factor in explaining individual differences in the microbiome.
That could change how studies are read. If earlier medications are ignored, scientists may blame a microbial difference on a disease or another health factor when past drug exposure played a part. Professor Elin Org, the corresponding author, described the work as a comprehensive, systematic evaluation of long-term medication effects using real-world health records, and said she hopes researchers and clinicians will factor in medication history when interpreting microbiome data.
The results also show how much is still unknown about the long-term relationship between medicines and gut bacteria, including what the lasting changes mean for the people who carry them.
Around Prague, based on reporting by ScienceDaily